SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
19-Nov-21 8:58 PM View: | Quince Therapeutics, Inc. (QNCX) | 18-Nov-21 | Option Exercise | 60,000 | $0.46 | $27,600.00 | 5% 1.12M to 1.18M | |
12-May-21 4:51 PM View: | Quince Therapeutics, Inc. (QNCX) | 10-May-21 | Market Sale (Planned) | 30,000 | $34.58 | $1,037,360.00 | (3%) 1.15M to 1.12M | (5%) |
23-Mar-21 7:06 PM View: | Quince Therapeutics, Inc. (QNCX) | 22-Mar-21 | Market Sale (Planned) | 30,000 | $35.59 | $1,067,610.00 | (3%) 1.18M to 1.15M | (< 1%) |
03-Feb-21 7:45 PM View: | Quince Therapeutics, Inc. (QNCX) | 03-Feb-21 | Market Sale (Planned) | 20,000 | $43.03 | $860,530.00 | (2%) 1.2M to 1.18M | |
03-Feb-21 7:45 PM View: | Quince Therapeutics, Inc. (QNCX) | 02-Feb-21 | Market Sale (Planned) | 20,000 | $36.21 | $724,102.00 | (2%) 1.22M to 1.2M | |
03-Feb-21 7:45 PM View: | Quince Therapeutics, Inc. (QNCX) | 01-Feb-21 | Market Sale (Planned) | 20,000 | $36.25 | $724,968.00 | (2%) 1.24M to 1.22M |